54 results
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
9 Jul 13
Regulation FD Disclosure
12:00am
resources, and environmental sciences for the Army, the Department of Defense, civilian agencies, and our nation’s public good.
About AASHTO TIG
AASHTO's
8-K
PCSA
Processa Pharmaceuticals Inc
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the previous 30 consecutive business days, the bid
10-K
2013 FY
EX-10.17
PCSA
Processa Pharmaceuticals Inc
27 Mar 14
Annual report
12:00am
company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity and a government or any department
8-K
EX-1.1
nuemkc m1nveeiwx1
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-99.1
133jcv4 zhb7l
9 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
rzcg5kpb4b0d3j9w 923
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
p5e5iak0m0rm
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am